Skip to main content
. 2017 May 11;8(31):51478–51491. doi: 10.18632/oncotarget.17807

Table 1. Cells viability in response to different treatment in HCT116, HCT-8/5-FU or NCM460.

Rate of cell survival (%)
HCT116 Control 5-FU DTN DHA 5-FU+DTN 5-FU+DHA DTN+DHA 5-FU+DTN+DHA
24h 100.03±8.08 98.61±12.04 98.49±8.79 104.80±10.12 94.65±7.14 97.62±9.24 96.51±9.22 89.51±10.28
48h 101.21±7.14 85.85±10.96 84.62±8.23* 90.43±8.08 75.71±6.16* 77.50±8.05* 79.14±10.56* 65.28±7.55*
72h 99.23±6.18 77.10±7.69* 73.24±10.02* 85.47±9.08 67.35±9.90* 69.14±7.11* 73.92±6.17* 57.80±7.13*
HCT-8/5-FU
24h 103.1±10.33 105.84±15.12 99.50±11.82 106.57±12.05 96.90±15.01 98.55±14.09 97.59±10.74 91.66±8.09
48h 98.92±7.42 95.81±9.17 90.02±7.05 91.16±11.21 79.53±9.24* 80.70±9.12* 87.31±9.05 70.36±8.27*
72h 100.09±9.17 89.65±7.21 84.60±6.31 86.80±8.84 74.24±8.15* 76.54±8.56* 83.42±10.07* 62.73±9.78*
NCM460
24h 100.78±15.41 105.40±8.87 102.20±12.02 105.7±13.01 98.22±18.06 98.93±16.23 98.57±12.04 100.34±12.23
48h 99.75±11.23 88.68±10.01 93.24±10.44 98.75±8.43 92.31±11.23 90.40±8.54 89.21±10.15 90.52±10.14
72h 101.43±13.32 81.56±7.55* 90.60±7.51 95.22±9.86 82.78±6.34 82.65±11.07 85.75±7.91 83.28±8.77

Notes: Data was showed as X¯±Sdn = 5. * p<0.05 showed a significant difference compared to control group